The biological properties of therapeutic compounds to degrade pathogenic microorganisms have been explained from organic chemistry perspective. Precisely, this paper has properly shown the mode of action concerning acidic therapeutic compounds possessing hydroxyl or carboxylic groups including alkaloid therapeutic compounds bearing a nitrogen atom or an amine group. In other words, this conceptual research has disclosed detailed reaction mechanisms, which demonstrate how an adequate medicine can neutralize or degrade one of the essential microbial cellular chemical constituents, such as the deoxyribonucleic acid (DNA).
References
[1]
Mwene-Mbeja, T.M. (2026) Applied Research: Conceptual Study of Cellular Membrane Organic Compounds Enzymatic Synthesis towards Promedicine of Dopamine and Cocaine Penetration into the Cytoplasm. Open Access Journal of Chemistry, 8, 50-73. https://doi.org/10.22259/2637-5834.0801003
[2]
Mickymaray, S. (2019) Efficacy and Mechanism of Traditional Medicinal Plants and Bioactive Compounds against Clinically Important Pathogens. Antibiotics, 8, Article 257. https://doi.org/10.3390/antibiotics8040257
[3]
Cruz, J., Ortiz, C., Guzmán, F., Fernández-Lafuente, R. and Torres, R. (2014) Antimicrobial Peptides: Promising Compounds against Pathogenic Microorganisms. Current Medicinal Chemistry, 21, 2299-2321. https://doi.org/10.2174/0929867321666140217110155
[4]
Riaz, M., Khalid, R., Afzal, M., Anjum, F., Fatima, H., Zia, S., et al. (2023) Phytobioactive Compounds as Therapeutic Agents for Human Diseases: A Review. Food Science & Nutrition, 11, 2500-2529. https://doi.org/10.1002/fsn3.3308
[5]
Amaning Danquah, C., Minkah, P.A.B., Osei Duah Junior, I., Amankwah, K.B. and Somuah, S.O. (2022) Antimicrobial Compounds from Microorganisms. Antibiotics, 11, Article 285. https://doi.org/10.3390/antibiotics11030285
[6]
Basalla, J., Chatterjee, P., Burgess, E., Khan, M., Verbrugge, E., Wiegmann, D.D., etal. (2019) Loci Encoding Compounds Potentially Active against Drug-Resistant Pathogens Amidst a Decreasing Pool of Novel Antibiotics. Applied and Environmental Microbiology, 85, e01438. https://doi.org/10.1128/aem.01438-19
[7]
Tiash, S., Saunders, J., Hart, C.J.S., Ryan, J.H., Riches, A.G. and Skinner-Adams, T.S. (2020) An Image-Based Pathogen Box Screen Identifies New Compounds with Anti-Giardia Activity and Highlights the Importance of Assay Choice in Phenotypic Drug Discovery. International Journal for Parasitology: Drugs and Drug Resistance, 12, 60-67. https://doi.org/10.1016/j.ijpddr.2020.03.002
[8]
Voorhees, P.M., Dees, E.C., O’Neil, B. and Orlowski, R.Z. (2003) The Proteasome as a Target for Cancer Therapy. Clinical Cancer Research, 9, 6316-6325.
[9]
Momose, I. and Kawada, M. (2016) The Therapeutic Potential of Microbial Proteasome Inhibitors. InternationalImmunopharmacology, 37, 23-30. https://doi.org/10.1016/j.intimp.2015.11.013
[10]
Moreira, W., Santhanakrishnan, S., Dymock, B.W. and Dick, T. (2017) Bortezomib Warhead-Switch Confers Dual Activity against Mycobacterial Caseinolytic Protease and Proteasome and Selectivity against Human Proteasome. Frontiers in Microbiology, 8, Article 746. https://doi.org/10.3389/fmicb.2017.00746
[11]
Sogbein, O., Paul, P., Umar, M., Chaari, A., Batuman, V. and Upadhyay, R. (2024) Bortezomib in Cancer Therapy: Mechanisms, Side Effects, and Future Proteasome Inhibitors. Life Sciences, 358, Article 123125. https://doi.org/10.1016/j.lfs.2024.123125
[12]
Wei, Y., Huang, M. and Jiang, L. (2024) Advancements in Serine Protease Inhibitors: From Mechanistic Insights to Clinical Applications. Catalysts, 14, Article 787. https://doi.org/10.3390/catal14110787
[13]
Zhang, Z., Chen, Y., Deng, J., Jia, X., Zhou, J. and Lv, H. (2014) Solid Dispersion of Berberine-Phospholipid Complex/TPGS 1000/SiO2: Preparation, Characterization and in Vivo Studies. International Journal of Pharmaceutics, 465, 306-316. https://doi.org/10.1016/j.ijpharm.2014.01.023
[14]
Mohapatra, N., Singh, T.G., Kumar, M. and Awasthi, A. (2026) A Comprehensive Compendium of Berberine: Sources, Chemistry, and Pharmacological Activities. Journal of the Science of Food and Agriculture, 106, 5142-5162. https://doi.org/10.1002/jsfa.70394
[15]
Mwene-Mbeja, T.M., Dufour, A., Lecka, J., Kaur, B.S. and Vaneeckhaute, C. (2020) Enzymatic Reactions in the Production of Biomethane from Organic Waste. Enzyme and Microbial Technology, 132, Article 109410. https://doi.org/10.1016/j.enzmictec.2019.109410
[16]
Zhu, P., Li, M., Yan, C., Sun, J., Peng, M., Huang, Z., et al. (2020) Aspirin Causes Lipid Accumulation and Damage to Cell Membrane by Regulating DCI1/OLE1 in Saccharomyces cerevisiae. Microbial Drug Resistance, 26, 857-868. https://doi.org/10.1089/mdr.2019.0200
[17]
Alsop, R.J., Toppozini, L., Marquardt, D., Ku？erka, N., Harroun, T.A. and Rheinst？dter, M.C. (2015) Aspirin Inhibits Formation of Cholesterol Rafts in Fluid Lipid Membranes. Biochimica et Biophysica Acta—Biomembranes, 1848, 805-812. https://doi.org/10.1016/j.bbamem.2014.11.023
[18]
Krmic, M., Perez, E., Scollan, P., Ivanchenko, K., Gamez Hernandez, A., Giancaspro, J., et al. (2023) Aspirin Interacts with Cholesterol-Containing Membranes in a pH-Dependent Manner. Langmuir, 39, 16444-16456. https://doi.org/10.1021/acs.langmuir.3c02242
[19]
Visagie, J.L., Aruwajoye, G.S. and van der Sluis, R. (2024) Pharmacokinetics of Aspirin: Evaluating Shortcomings in the Literature. Expert Opinion on Drug Metabolism & Toxicology, 20, 727-740. https://doi.org/10.1080/17425255.2024.2386368
[20]
Knobloch, J., Suhendro, D.K., Zieleniecki, J.L., Shapter, J.G. and K？per, I. (2015) Membrane-Drug Interactions Studied Using Model Membrane Systems. Saudi Journal of Biological Sciences, 22, 714-718. https://doi.org/10.1016/j.sjbs.2015.03.007
[21]
Lucio, M., Lima, J.L.F.C. and Reis, S. (2010) Drug-Membrane Interactions: Significance for Medicinal Chemistry. Current Medicinal Chemistry, 17, 1795-1809. https://doi.org/10.2174/092986710791111233
[22]
Lysenko, V., Gao, M.L., Sterk, F.A.C., Innocenti, P., Slingerland, C.J. and Martin, N.I. (2025) Design, Synthesis, and Antibacterial Evaluation of Rifampicin-Siderophore Conjugates. ACSInfectiousDiseases, 11, 2301-2309. https://doi.org/10.1021/acsinfecdis.5c00311
[23]
Le-Deygen, I.M., Safronova, A.S., Mamaeva, P.V., Kolmogorov, I.M., Skuredina, A.A. and Kudryashova, E.V. (2022) Drug-Membrane Interaction as Revealed by Spectroscopic Methods: The Role of Drug Structure in the Example of Rifampicin, Levofloxacin and Rapamycin. Biophysica, 2, 353-365. https://doi.org/10.3390/biophysica2040032
[24]
Singh, C., Bhatt, T.D., Gill, M.S. and Suresh, S. (2014) Novel Rifampicin-Phospholipid Complex for Tubercular Therapy: Synthesis, Physicochemical Characterization and In-Vivo Evaluation. International Journal of Pharmaceutics, 460, 220-227. https://doi.org/10.1016/j.ijpharm.2013.10.043
[25]
Santos, R.M.S., Samelo, J., Oliveira, A.C., Cordeiro, M.M., Mora, M.J., Granero, G.E., et al. (2025) Interaction of the Antibiotic Rifampicin with Lipid Membranes. Biomolecules, 15, Article 320. https://doi.org/10.3390/biom15030320
[26]
Kubala, M., Teisinger, J., Ettrich, R., Hofbauerová, K., Kopecky, V., Baumruk, V., etal. (2003) Eight Amino Acids Form the ATP Recognition Site of Na+/K+-ATPase. Biochemistry, 42, 6446-6452. https://doi.org/10.1021/bi034162u
[27]
Bisello, G., Rossignoli, G., Choi, S., Phillips, R.S. and Bertoldi, M. (2023) Active Site Serine-193 Modulates Activity of Human Aromatic Amino Acid Decarboxylase. Biochemical and Biophysical Research Communications, 679, 6-14. https://doi.org/10.1016/j.bbrc.2023.08.049
[28]
Li, T., Huo, L., Pulley, C. and Liu, A. (2012) Decarboxylation Mechanisms in Biological System. Bioorganic Chemistry, 43, 2-14. https://doi.org/10.1016/j.bioorg.2012.03.001
